October 9, 2026
avatar-torie-bosch
First Opinion Editor

Due to my boneheaded error, last week’s newsletter incorrectly included the intro from the previous week. I’m sorry!

I’ve been thinking lately about how to beef up First Opinion’s coverage of biotech and pharma. I have a special place in my heart for the more general interest pieces — public health, the practice of medicine, the experience of being a patient, policy — but I’d love to expand our offerings on biopharma. I want to hear from you: Should I be publishing more pieces on drug development, research, the biopharma workforce, etc.? If so, what do you want to read? Who do you want to hear from? This is a complicated space, of course — CEOs want to write fairly bland pieces, and many writers have financial conflicts of interest. So I want to make sure that I’m bringing fair, surprising arguments that aren’t overly influenced by the writer’s personal fortunes. What might that look like? Should we launch a new biotech columnist? Let me know.

***

I’ll be at the STAT Summit in Boston on Wednesday and Thursday. Come find me and say hello! Don’t have your tickets yet? Get ’em now!

In other exciting STAT news, this week we announced our latest crop of Wunderkinds. It’s our 10th year recognizing rising stars in medicine and research, and as usual, it’s an inspiring and exciting bunch. One of the Wunderkinds even wrote a First Opinion just this week: Leah Pierson, a resident physician at Brigham and Women’s Hospital who studies ethics, weighed in on “bump codes” and AI tools inflating health care costs.

Recommendation of the week: Last month, BritBox shows began appearing on HBO Max, much to my delight. One of them is the first season of the binge-worthy “Outrageous,” a show about the real-life Mitford sisters. “The Six,” as they were known, came from a prominent family down on its luck and became a fascination to mid-20th-century Britain, in part because of their wildly differing politics. Author Ben Macintyre once referred to them as “Diana the Fascist, Jessica the Communist, Unity the Hitler-lover, Nancy the Novelist, Deborah the Duchess and Pamela the unobtrusive poultry connoisseur."



STAT/The Irkutsk Anti-Plague Research Institute of Siberia and Far East via AP

Infectious disease expert: The mysterious pneumonia in Russia deserves attention, not panic

Amid reports of a lab worker dying of an unexplained pneumonia, people are jumping far ahead of the evidence.

By Krutika Kuppalli


50 years ago, my colleagues and I pursued basic research science that became revolutionary

The scientist who discovered human retroviruses explains how his basic science research can lead to unexpected places.

By Robert C. Gallo


Proposed U.S. census changes could be catastrophic for public health

Proposed changes to 2030 U.S. census would make it harder to track health trends, offer aid, and much more.

By Nancy Krieger


Adobe

Will Claude ever win a Nobel Prize for medicine?

As AI becomes capable of scientific discovery, who gets credit? A Nobel Prize for an AI agent could force science to rethink how discovery is rewarded.

By Jeffrey S. Flier


England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?

The world has made great strides in eliminating hepatitis C. But the U.S. remains far behind.

By Philip A. Chan, Alan Epstein,and Amy Nunn


How CMS plans to fix a major flaw in the 340B drug discount program

The 340B drug discount program has brought unintended consequences — and cost. CMS wants to address that.

By Casey B. Mulligan


Adobe

My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’

When a man with Gleason 6 prostate cancer went to get life insurance, he found out that companies see active surveillance as a lack of treatment.

By Howard Wolinsky


Why the FDA should not approve an ineffective multicancer screening test

An FDA advisory committee recommends approving Grail’s multi-cancer screening test. A cancer screening researcher disagrees.

By H. Gilbert Welch


I’m a doctor. Here’s what I want the public to know about AI tools and health care costs

A physician examines recently published research suggesting hospitals use AI tools to extract money from insurers.

By Leah Pierson


Aaron Davidson/Getty Images for CELSIUS

Energy drinks’ new college sports partnerships make them more dangerous than ever

In addressing the health risks of kids and energy drinks, public health should learn from the fights against tobacco, drunk driving.

By Kent Sepkowitz


More around STAT

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.